Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma

Anticancer Research

Volumn 28, Issue 2 A, 2008, Pages 763-769

  Berardi, Anna C ^a   Marsilio, Sonia ^a,b   Rofani, Cristina ^a   Salvucci, Ombretta ^c   Altavista, Pierluigi ^d   Perla, Francesco M ^b   Diomedi Camassei, Francesca ^a   Uccini, Stefania ^b   Kokai, George ^f   Landuzzi, Lorena ^e   McDowell, Heather P ^f   Dominici, Carlo ^a,b,g  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d ENEA C R CASACCIA   (Italy)

^e RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^f ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

EphB receptors; Ephrin B; Rhabdomyosarcoma

Indexed keywords

EPHRIN RECEPTOR B1; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B3; EPHRIN RECEPTOR B4; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SKELETAL MUSCLE; UPREGULATION;

CELL LINE, TUMOR; EPHRIN-B1; EPHRIN-B2; EPHRINS; HUMANS; LIGANDS; RECEPTORS, EPH FAMILY; RHABDOMYOSARCOMA; RNA, MESSENGER; UP-REGULATION;

EID: 42549091032     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gurney JG, Young Jr JL, Roffers SD, Smith MA and Bunin GR: Soft tissue sarcomas. In: Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young Jr JL and Bunin GR (eds.). Bethesda, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. pp. 111-123, 1999.
2. Qualman SJ, Coffin CM, Newton WA, Hojo H, Triche TJ, Parham DM and Crist WM: Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1: 550-561, 1998.
3. McDowell HP: Update on childhood rhabdomyosarcoma. Arch Dis Child 88: 354-357, 2003.
4. Breitfeld PP and Meyer WH: Rhabdomyosarcoma: new windows of opportunity. The Oncologist 10: 518-527, 2005.
5. Barr FG: Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 20: 5736-5746, 2001.
6. Pasquale EB: Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6: 462-475, 2005.
7. Eph Nomenclature Committee: Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell 90: 403-404, 1997.
8. Brückner K and Klein R: Signaling by Eph receptors and their ephrin ligands. Curr Opin Neurobiol 8: 375-382, 1998.
9. Kullander K and Klein R: Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 3: 475-486, 2002.
10. Pasquale EB: The Eph family of receptors. Curr Opin Cell Biol 9: 608-615, 1997.
11. Coulthard MG, Duffy S, Down M, Evans B, Power M, Smith F, Stylianou C, Kleikamp S, Oates A, Lackmann M, Burns GF and Boyd AW: The role of the Eph-ephrin signalling system in the regulation of developmental patterning. Int J Dev Biol 46: 375-384, 2002.
12. Cheng N, Brantley DM and Chen J: The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13: 75-85, 2002.
13. Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003.
14. Sahai E: Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15: 87-96, 2005.
15. Christofori G: New signals from the invasive front. Nature 441: 444-450, 2006.
16. Nakamoto M and Bergemann AD: Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. Microsc Res Tech 59: 58-67, 2002.
17. Surawska H, Ma PC and Salgia R: The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 15: 419-433, 2004.
18. Heroult M, Schaffner F and Augustin HG: Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp Cell Res 312: 642-650, 2006.
19. Tang XX, Zhao H, Robinson ME, Cnaan A, London W, Cohn SL, Cheung NK, Brodeur GM, Evans AE and Ikegaki N: Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc Natl Acad Sci USA 97: 10936-10941, 2000.
20. Lai KO, Ip FC, Cheung J, Fu AK and Ip NY: Expression of Eph receptors in skeletal muscle and their localization at the neuromuscular junction. Mol Cell Neurosi 17: 1034-1047, 2001.
21. Swartz ME, Eberhart J, Pasquale EB and Krull CE: EphA4/ephrin-A5 interactions in muscle precursor cell migration in the avian forelimb. Development 128: 4669-4680, 2001.
22. Houghton JA, Houghton PJ, Brodeur GM and Green AA: Development of resistance to vincristine in a childhood rhabdomyosarcoma growing in immune-deprived mice. Int J Cancer 28: 409-415, 1981.
23. Nanni P, Schiaffino S, De Giovanni C, Nicoletti G, Prodi G, Del Re B, Eusebi V, Ceccarelli C, Saggini L and Lollini PL: RMZ: a new cell line from a human alveolar rhabdomyo-sarcoma: in vitro expression of embryonic myosin. Br J Cancer 54: 1009-1114, 1986.
24. Douglass EC, Valentine M, Etcubanas E, Parham D, Webber BL, Houghton PJ, Houghton JA and Green AA: A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 45: 148-155, 1987.
25. De Giovanni C, Nanni P, Nicoletti G, Ceccarelli C, Scotlandi K, Landuzzi L and Lollini PI: Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA). Anticancer Res 9: 1943-1949, 1989.
26. Lollini PL, De Giovanni C, Landuzzi L, Nicoletti G, Scotlandi K and Nanni P: Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells. Invasion Metastasis 11: 116-124, 1991.
27. Wimmer-Kleikamp SH and Lackmann M: Eph-modulated cell morphology, adhesion and motility in carcinogenesis. IUBMB Life 57: 421-431, 2005.
28. Adams RH: Vascular patterning by Eph receptor tyrosine kinases and ephrins. Semin Cell Dev Biol 13: 55-60, 2002.
29. Zhang J and Hughes S: Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol 208: 453-461, 2006.
30. Salvucci O, de la Luz Sierra M, Martina JA, McCormick PJ and Tosato G: EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. Blood 108: 2914-2922, 2006.
31. Wu Q, Suo Z, Risberg B, Villman K and Nesland JM: Expression of Ephb2 and Ephb4 in breast carcinoma. Pathol Oncol Res 10: 26-33, 2004.
32. Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M, Malats N, Sancho E, Boon E, Pawson T, Gallinger S, Pals S and Clevers H: EphB receptor activity suppresses colorectal cancer progression. Nature 435: 1126-1130, 2005.